Email address
[email protected]Contact number
(+1) 917 613-0709Share profile
Band 3
Provided by James C Fitzpatrick
James C. Fitzpatrick is Co-Chair of Hughes Hubbard’s Product Liability practice group and a member of the firm’s Litigation department. His practice focuses on domestic and international pharmaceutical and product liability litigation as well as other types of complex commercial litigation.
Jim’s practice also includes the development and presentation of scientific issues at trial, in the media, and as part of Congressional and Department of Justice investigations. He has litigated securities and Employee Retirement Income Security Act matters in the pharmaceutical area, as well as product liability trials in the US and around the world.
Provided by Chambers
James Fitzpatrick frequently defends pharmaceutical clients against high-profile MDLs on a national and international scale. He is especially well-versed in defending litigation involving vaccines.
Provided by Chambers
James has unique ability to form relationships of trust with experts.
James Fitzpatrick is an outstanding lawyer with deep expertise in pharmaceutical and scientific matters. He brings a rare combination of technical understanding and strategic legal thinking.
James is extremely knowledgeable on the science within product liability litigation. He is also a tremendous resource when it comes to handling local or international expert witnesses.
James stands out with his deep knowledge of the scientific and regulatory issues raised by a case.
James has unique ability to form relationships of trust with experts.
James Fitzpatrick is an outstanding lawyer with deep expertise in pharmaceutical and scientific matters. He brings a rare combination of technical understanding and strategic legal thinking.
James is extremely knowledgeable on the science within product liability litigation. He is also a tremendous resource when it comes to handling local or international expert witnesses.
James stands out with his deep knowledge of the scientific and regulatory issues raised by a case.